These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mitoxantrone: a review of its use in multiple sclerosis. Scott LJ; Figgitt DP CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110 [TBL] [Abstract][Full Text] [Related]
3. Long term effect of delayed treatment on disability in patients with paediatric onset multiple sclerosis: A prospective Danish cohort study. Kopp TI; Blinkenberg M; Petersen T; Sorensen PS; Magyari M Mult Scler Relat Disord; 2020 May; 40():101956. PubMed ID: 32007654 [TBL] [Abstract][Full Text] [Related]
4. Contribution of relapses to disability in multiple sclerosis. Hirst C; Ingram G; Pearson O; Pickersgill T; Scolding N; Robertson N J Neurol; 2008 Feb; 255(2):280-7. PubMed ID: 18204919 [TBL] [Abstract][Full Text] [Related]
5. How patients with multiple sclerosis acquire disability. Lublin FD; Häring DA; Ganjgahi H; Ocampo A; Hatami F; Čuklina J; Aarden P; Dahlke F; Arnold DL; Wiendl H; Chitnis T; Nichols TE; Kieseier BC; Bermel RA Brain; 2022 Sep; 145(9):3147-3161. PubMed ID: 35104840 [TBL] [Abstract][Full Text] [Related]
6. Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting. Trojano M; Butzkueven H; Kappos L; Wiendl H; Spelman T; Pellegrini F; Chen Y; Dong Q; Koendgen H; Belachew S; Mult Scler Relat Disord; 2018 Aug; 24():11-19. PubMed ID: 29860197 [TBL] [Abstract][Full Text] [Related]
8. Contribution of relapse-associated worsening to overall disability accrual in patients with relapsing-onset multiple sclerosis: A mediation analysis. Chen B; Ji SQ; Shen F; Tian DS; Bu BT Mult Scler Relat Disord; 2022 Mar; 59():103555. PubMed ID: 35093839 [TBL] [Abstract][Full Text] [Related]
9. Worsening of disability caused by relapses in multiple sclerosis: A different approach. Koch-Henriksen N; Thygesen LC; Sørensen PS; Magyari M Mult Scler Relat Disord; 2019 Jul; 32():1-8. PubMed ID: 31003200 [TBL] [Abstract][Full Text] [Related]
10. Relapses add to permanent disability in relapsing multiple sclerosis patients. Koch-Henriksen N; Sørensen PS; Magyari M Mult Scler Relat Disord; 2021 Aug; 53():103029. PubMed ID: 34116481 [TBL] [Abstract][Full Text] [Related]
11. Risk of Persistent Disability in Patients With Pediatric-Onset Multiple Sclerosis. Baroncini D; Simone M; Iaffaldano P; Brescia Morra V; Lanzillo R; Filippi M; Romeo M; Patti F; Chisari CG; Cocco E; Fenu G; Salemi G; Ragonese P; Inglese M; Cellerino M; Margari L; Comi G; Zaffaroni M; Ghezzi A; JAMA Neurol; 2021 Jun; 78(6):726-735. PubMed ID: 33938921 [TBL] [Abstract][Full Text] [Related]
12. Impact of multiple sclerosis relapses on progression diminishes with time. Tremlett H; Yousefi M; Devonshire V; Rieckmann P; Zhao Y; Neurology; 2009 Nov; 73(20):1616-23. PubMed ID: 19890070 [TBL] [Abstract][Full Text] [Related]
13. Decreasing impact of late relapses on disability worsening in secondary progressive multiple sclerosis. Ahrweiller K; Rousseau C; Le Page E; Bajeux E; Leray E; Michel L; Edan G; Kerbrat A Mult Scler; 2020 Jul; 26(8):924-935. PubMed ID: 31094285 [TBL] [Abstract][Full Text] [Related]
14. Contribution of different relapse phenotypes to disability in multiple sclerosis. Stewart T; Spelman T; Havrdova E; Horakova D; Trojano M; Izquierdo G; Duquette P; Girard M; Prat A; Lugaresi A; Grand'Maison F; Grammond P; Sola P; Shaygannejad V; Hupperts R; Alroughani R; Oreja-Guevara C; Pucci E; Boz C; Lechner-Scott J; Bergamaschi R; Van Pesch V; Iuliano G; Ramo C; Taylor B; Slee M; Spitaleri D; Granella F; Verheul F; McCombe P; Hodgkinson S; Amato MP; Vucic S; Gray O; Cristiano E; Barnett M; Sanchez Menoyo JL; van Munster E; Saladino ML; Olascoaga J; Prevost J; Deri N; Shaw C; Singhal B; Moore F; Rozsa C; Shuey N; Skibina O; Kister I; Petkovska-Boskova T; Ampapa R; Kermode A; Butzkueven H; Jokubaitis V; Kalincik T; Mult Scler; 2017 Feb; 23(2):266-276. PubMed ID: 27055805 [TBL] [Abstract][Full Text] [Related]